Hanmi Pharm Co Ltd
KRX:128940

Watchlist Manager
Hanmi Pharm Co Ltd Logo
Hanmi Pharm Co Ltd
KRX:128940
Watchlist
Price: 240 000 KRW 0.21% Market Closed
Market Cap: 3.1T KRW

Intrinsic Value

The intrinsic value of one Hanmi Pharm Co Ltd stock under the Base Case scenario is 372 646.19 KRW. Compared to the current market price of 240 000 KRW, Hanmi Pharm Co Ltd is Undervalued by 36%.

Intrinsic Value
372 646.19 KRW
Undervaluation 36%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Hanmi Pharm Co Ltd

Hanmi Pharm Co Ltd
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for Hanmi Pharm Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Hanmi Pharm Co Ltd
KRX:128940
KR
Pharmaceuticals
Market Cap
3T KRW
IPO
Jul 30, 2010
KR
Pharmaceuticals
Market Cap
3T KRW
IPO
Jul 30, 2010
Price
â‚©false
EPS
â‚©false
Company Overview
Loading...
Business Segments
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Hanmi Pharm Co Ltd?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Hanmi Pharm Co Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Hanmi Pharm Co Ltd

Current Assets 746.3B
Cash & Short-Term Investments 192.4B
Receivables 239.3B
Other Current Assets 314.6B
Non-Current Assets 1.3T
Long-Term Investments 176.3B
PP&E 822.5B
Intangibles 94.1B
Other Non-Current Assets 181.6B
Efficiency

Free Cash Flow Analysis
Hanmi Pharm Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Hanmi Pharm Co Ltd

Revenue
1.5T KRW
Cost of Revenue
-678.5B KRW
Gross Profit
817B KRW
Operating Expenses
-600.9B KRW
Operating Income
216.2B KRW
Other Expenses
-94.9B KRW
Net Income
121.3B KRW
Fundamental Scores

Profitability Score
Profitability Due Diligence

Hanmi Pharm Co Ltd's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Revenue Growth Forecast
Positive 3-Years Revenue Growth
58/100
Profitability
Score

Hanmi Pharm Co Ltd's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Hanmi Pharm Co Ltd's solvency score is 59/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
59/100
Solvency
Score

Hanmi Pharm Co Ltd's solvency score is 59/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Hanmi Pharm Co Ltd

Wall Street analysts forecast Hanmi Pharm Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Hanmi Pharm Co Ltd is 359 689.09 KRW with a low forecast of 292 900 KRW and a high forecast of 409 500 KRW.

Lowest
Price Target
292 900 KRW
22% Upside
Average
Price Target
359 689.09 KRW
50% Upside
Highest
Price Target
409 500 KRW
71% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Hanmi Pharm Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one Hanmi Pharm Co Ltd stock?

The intrinsic value of one Hanmi Pharm Co Ltd stock under the Base Case scenario is 372 646.19 KRW.

Is Hanmi Pharm Co Ltd stock undervalued or overvalued?

Compared to the current market price of 240 000 KRW, Hanmi Pharm Co Ltd is Undervalued by 36%.

Back to Top